My Colorectal Cancer is stable but not shrinking — is treatment still working

Understanding Stable Disease in Colorectal Cancer

This is an excellent and important question. The short answer is: yes, stable disease can represent meaningful treatment success, though it requires careful discussion with your oncology team about what this means for your specific situation.

What "Stable Disease" Actually Means

Stable disease means your cancer is not growing and not shrinking — it's staying roughly the same size on imaging scans. This is different from:

• Partial response: Cancer shrinks by 30% or more
• Complete response: All visible cancer disappears
• Progressive disease: Cancer grows by 20% or more

Why Stable Disease Can Be Valuable

According to recent clinical perspectives shared by oncologists, stable disease represents real clinical benefit, even though it's not a "response" in the traditional sense. Here's why:

1. Disease Control = Extended Survival As one experienced oncologist noted in clinical discussions: "If I could get my disease to stop spreading, one day I'll die of a heart attack or get hit by a bus. That seems like a pretty good option." Stopping cancer growth buys you time — potentially years of additional life.

2. Quality of Life Matters Stable disease often means:

• Fewer symptoms from cancer progression
• More time with family and loved ones
• Opportunity to explore additional treatment options
• Maintained functional status and independence

3. It's a Platform for Next Steps Stable disease gives your medical team time to:

• Monitor for any changes in the cancer's behavior
• Evaluate whether to continue, modify, or switch treatments
• Identify emerging treatment opportunities
• Assess your tolerance and side effects

Important Clinical Context for Colorectal Cancer

For colorectal cancer specifically, treatment decisions depend on several factors:

Stage of Disease:

• Early-stage (I-III) with no visible disease: Stable disease after surgery and chemotherapy is excellent — your goal is preventing recurrence
• Advanced/metastatic disease: Stable disease represents disease control and is often considered successful treatment

Treatment Goals: According to NCCN Guidelines for colorectal cancer, the primary objectives are:

• Controlling disease progression
• Extending overall survival
• Maintaining quality of life
• Managing side effects

Stable disease achieves the first three of these goals.

Questions to Ask Your Oncologist

Since stable disease can mean different things depending on your specific situation, here are targeted questions:

1. "Is this stable disease what we expected at this point in treatment, or is it different from our original plan?"

   • This helps clarify if you're on track or if adjustments are needed

2. "How long do you expect the disease to remain stable on this treatment?"

   • Helps you understand the timeline and when reassessment might occur

3. "What are the signs that would prompt us to change treatment?"

   • Defines clear decision points (e.g., growth by X%, new symptoms, new lesions)

4. "Are there any clinical trials or newer treatments we should consider while disease is stable?"

   • Stable disease is often the ideal time to explore additional options

5. "How frequently will we scan/monitor, and what's our plan if disease starts progressing?"

   • Establishes surveillance strategy and contingency planning

The Bigger Picture

Recent clinical discussions emphasize that oncologists and patients should have explicit conversations about what constitutes treatment success. Stable disease isn't failure — it's often the realistic goal, especially in advanced cancer. The key is ensuring you and your team have aligned expectations about:

• What you're trying to achieve
• How you'll measure success
• When you'll reassess the plan
• What "next steps" look like if things change

Important Reminder

The interpretation of stable disease in YOUR specific case — including whether to continue current treatment, modify it, or explore alternatives — depends on factors only your oncology team can fully evaluate:

• Your overall health and performance status
• Side effects you're experiencing
• Your cancer stage and location
• Specific biomarkers (MSI status, KRAS mutations, etc.)
• Your personal goals and preferences

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.